Clinical and Genome Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer
      QxMD      Google Scholar   
Citation:
Clin Cancer Res vol 23 (19) 5757-68
Year:
2017
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
7
Parents:
None
Children:
None
Program:
TRP
Primary Committee:
PPP
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821 , R01 DA006227, R01 MH101782, R01 MH101810, P50 MH094267, R01 MH101819, U24 GM115370, U10 CA180821, R01 DA033684, R01 MH090936, R01 CA157823, R01 MH090951, R01 MH101820, R01 MH101825, R01 MH090948, R01 MH090941, R01 MH101822, HHSN261200800001C, R01 MH090937, HHSN268201000029C, HHSN261200800001E, R01 MH101814  
Corr. Author:
 
Authors:
                                       
Networks:
 
Study
CALGB-90401
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
cisplatin, peripheral neuropathy, genome wide association study, cancer survivorship, Platinum Study, young adult, testicular cancer, germ cell tumor, patient reported outcomes, pharmacogenetics